Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of maribavir for cytomegalovirus infection in children and adol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Phase 3 | Status: RECRUITING